International Market Access Consulting (IMAC), consists of a global team of passionate individuals with decades of industry and consulting experience. Our team provides custom, high-impact, market access strategies and specialized, evidence‑based tools to effectively communicate the value of your product to key stakeholders in the payer landscape. As a specialist market access consulting company with a proven track record of success, we possess a high level of technical and scientific expertise to help our clients achieve their goals of optimized patient access for their products.
Philipp Frieden
Philipp Frieden is a PhD candidate in epidemiology at Université Laval, specializing in health economics and cardiovascular disease prevention. He has contributed to research at CHU de Québec's Health Technology Assessment Unit and has published peer-reviewed work on statin therapy and aortic stenosis. He applies this expertise in economic evaluation, health technology assessment, and medico-administrative data analysis to support evidence-based decisions in health and market access consulting.